Positron Emission Tomography Neuroimaging in Neurodegenerative Diseases: Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis

Neurologia i Neurochirurgia Polska - Poland
doi 10.5603/pjnns.a2019.0013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

VM Media SP. zo.o VM Group SK

Related search

Value Of18Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis

JAMA Neurology
Neurology
2014English

Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease

Open Journal of Neuroscinece
2013English

Tracking Neuroinflammation in Alzheimer’s Disease: The Role of Positron Emission Tomography Imaging

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Positron Emission Tomography in Breast Disease

Breast Cancer Research
Cancer ResearchOncology
2008English

Amyotrophic Lateral Sclerosis Disease and Environmental Risk Factors

Handbook of Research on Global Environmental Changes and Human Health
2019English

The Association betweenC9orf72Repeats and Risk of Alzheimer’s Disease and Amyotrophic Lateral Sclerosis: A Meta-Analysis

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2016English

Association Between Alzheimer Disease and Amyotrophic Lateral Sclerosis?

Canadian Journal of Neurological Sciences
MedicineNeurology
1990English

Retinal Thinning in Amyotrophic Lateral Sclerosis Patients Without Ophthalmic Disease

PLoS ONE
Multidisciplinary
2017English

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders

JAMA - Journal of the American Medical Association
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy